Biopharma at a Crossroads: Where Investors Can Find Growth
The biotechnology sector is going through the longest “downturn” in its history, while at the same time science is generating revolutionary breakthroughs — from curing genetic diseases to drugs capable of dramatically improving the health of entire nations. Ilya Yasny, Head of Scientific Expertise at LanceBio Ventures, explains how this market works, where real breakthrough technologies are hidden, and how to distinguish them from unfounded hype.